Benincosa LJ - Search Results

1

Pharmacokinetics and pharmacodynamics of a humanized monoclonal antibody to factor IX in cynomolgus monkeys.

Benincosa LJ, Chow FS, Tobia LP, Kwok DC, Davis CB, Jusko WJ. Benincosa LJ, et al. J Pharmacol Exp Ther. 2000 Feb;292(2):810-6. J Pharmacol Exp Ther. 2000. PMID: 10640322

2

Pharmacokinetic and pharmacodynamic modeling of humanized anti-factor IX antibody (SB 249417) in humans.

Chow FS, Benincosa LJ, Sheth SB, Wilson D, Davis CB, Minthorn EA, Jusko WJ. Chow FS, et al. Among authors: benincosa lj. Clin Pharmacol Ther. 2002 Apr;71(4):235-45. doi: 10.1067/mcp.2002.122276. Clin Pharmacol Ther. 2002. PMID: 11956506 Clinical Trial.

3

Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to human interleukin-5, in monkeys.

Zia-Amirhosseini P, Minthorn E, Benincosa LJ, Hart TK, Hottenstein CS, Tobia LA, Davis CB. Zia-Amirhosseini P, et al. Among authors: benincosa lj. J Pharmacol Exp Ther. 1999 Dec;291(3):1060-7. J Pharmacol Exp Ther. 1999. PMID: 10565825

4

An overview of the pharmacokinetics of cilomilast (Ariflo), a new, orally active phosphodiesterase 4 inhibitor, in healthy young and elderly volunteers.

Zussman BD, Benincosa LJ, Webber DM, Clark DJ, Cowley H, Kelly J, Murdoch RD, Upward J, Wyld P, Port A, Fuder H. Zussman BD, et al. Among authors: benincosa lj. J Clin Pharmacol. 2001 Sep;41(9):950-8. doi: 10.1177/00912700122010924. J Clin Pharmacol. 2001. PMID: 11549099 Clinical Trial.

5

Assessment of the potential pharmacokinetic and pharmacodynamic interactions between erythromycin and argatroban.

Tran JQ, Di Cicco RA, Sheth SB, Tucci M, Peng L, Jorkasky DK, Hursting MJ, Benincosa LJ. Tran JQ, et al. Among authors: benincosa lj. J Clin Pharmacol. 1999 May;39(5):513-9. J Clin Pharmacol. 1999. PMID: 10234600 Clinical Trial.

6

Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration.

Zheng Y, Tesar DB, Benincosa L, Birnböck H, Boswell CA, Bumbaca D, Cowan KJ, Danilenko DM, Daugherty AL, Fielder PJ, Grimm HP, Joshi A, Justies N, Kolaitis G, Lewin-Koh N, Li J, McVay S, O'Mahony J, Otteneder M, Pantze M, Putnam WS, Qiu ZJ, Ruppel J, Singer T, Stauch O, Theil FP, Visich J, Yang J, Ying Y, Khawli LA, Richter WF. Zheng Y, et al. MAbs. 2012 Mar-Apr;4(2):243-55. doi: 10.4161/mabs.4.2.19387. Epub 2012 Mar 1. MAbs. 2012. PMID: 22453096 Free PMC article.

7

Pharmacokinetics and absolute bioavailability of epristeride in healthy male subjects.

Benincosa LJ, Audet PR, Lundberg D, Zariffa N, Jorkasky DK. Benincosa LJ, et al. Biopharm Drug Dispos. 1996 Apr;17(3):249-58. doi: 10.1002/(SICI)1099-081X(199604)17:3<249::AID-BDD952>3.0.CO;2-E. Biopharm Drug Dispos. 1996. PMID: 8983399 Clinical Trial.

8

Ibuprofen-induced changes in sulfate renal transport.

Sagawa K, Benincosa LJ, Murer H, Morris ME. Sagawa K, et al. Among authors: benincosa lj. J Pharmacol Exp Ther. 1998 Dec;287(3):1092-7. J Pharmacol Exp Ther. 1998. PMID: 9864297

9

Model-based drug development.

Lalonde RL, Kowalski KG, Hutmacher MM, Ewy W, Nichols DJ, Milligan PA, Corrigan BW, Lockwood PA, Marshall SA, Benincosa LJ, Tensfeldt TG, Parivar K, Amantea M, Glue P, Koide H, Miller R. Lalonde RL, et al. Among authors: benincosa lj. Clin Pharmacol Ther. 2007 Jul;82(1):21-32. doi: 10.1038/sj.clpt.6100235. Epub 2007 May 23. Clin Pharmacol Ther. 2007. PMID: 17522597 Review.

10

Renal adaptation to altered dietary sulfate in rats.

Benincosa LJ, Sagawa K, Morris ME. Benincosa LJ, et al. J Pharmacol Exp Ther. 1995 Jan;272(1):248-55. J Pharmacol Exp Ther. 1995. PMID: 7815339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters